Can erectile dysfunction drugs improve lower urinary tract symptoms in men with benign prostatic hyperplasia?
ANAHEIM, Ca. (May 22, 2007) — Early research has explored a possible connection between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) and has also suggested that LUTS associated with benign prostatic hyperplasia (BPH) may be improved with phosphodiesterase (PDE) inhibitors drugs commonly prescribed for certain types of ED. The inhibition of PDE isoenzymes relaxes the smooth muscle in the prostate or bladderand can improve LUTS in BPH patients. Three studies presented during the 102nd Annual Scientific Meeting of the American Urological Association (AUA) focus on the use of PDE-5 inhibitors in treating men with co-existent LUTS and ED. A special session for media moderated by Kevin T. McVary, M.D. was held on Tuesday, May 22, 2007 at 9:00 a.m.
